PF-05221304 SECRETS

Treatment method with SR18662 substantially lowers expansion and proliferation of CRC cells. SR18662 shows enhanced efficacy in lowering viability of a number of CRC cell lines. Movement cytometry Examination adhering to SR18662 treatment exhibits an increase in cells captured in possibly S or G2/M phases in the cell cycle and a significant rise in